The 20 Best Hypoparathyroidism Doctors Near Me in Brighton, MI

Kara Mizokami-Stout, MD, MSc is an Assistant Professor of Internal Medicine with an appointment in the Division of Metabolism, Endocrinology, and Diabetes. She attended medical school and internal medicine residency at the University of Colorado. She then completed her endocrinology fellowship at the University of Michigan. She joined the faculty at the University of Michigan in 2017 and has a dual appointment at the Ann Arbor VA.Dr. Mizokami-Stout’s practice focuses on type 1 diabetes, type 2 diabetes, and general endocrinology. She also conducts health services research in the field of diabetes. Dr. Mizokami is rated as an Experienced provider by MediFind in the treatment of Hypoparathyroidism. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Diabetic Neuropathy, Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), and Graves Disease. Dr. Mizokami is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

David T. Broome, MD, is a Clinical Assistant Professor of Medicine in the Metabolism, Endocrinology, and Diabetes (MEND) Division of the University of Michigan. Dr. Broome's clinical and research interests are in Type 1 Diabetes Mellitus, Atypical Diabetes and Monogenic Diabetes (including MODY), Type 2 Diabetes Mellitus, Hypoglycemia, Thyroid Cancer and Primary Hyperparathyroidism. Dr. Broome is dedicated to progress in scholarly work, translational research, and was the recipient of the Tait Endowed Research Scholarship for his work in diabetes in medical school, selected to the Clinical Scholars Program in residency, and several research and teaching thereafter, including: the Cleveland Clinic Foundation Endocrinology & Metabolism Institute Research Award, ENDO Experience Travel Award, the Cleveland Clinic Lerner College of Medicine Excellence in Teaching Award, the AACE Domestic Resident Travel Grant, and most recently the Michigan Clinical Trials Academy. Dr. Broome currently serves as a Review Editor on the editorial board for Frontiers in Clinical Diabetes and Healthcare. In his free time, Dr. Broome enjoys ice hockey, cycling, and spending time with family and friends on the beach in Holland, MI. Dr. Broome is rated as an Experienced provider by MediFind in the treatment of Hypoparathyroidism. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Familial Partial Lipodystrophy, Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Gestational Diabetes, and Parathyroidectomy. Dr. Broome is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Nada Fanous is an Internal Medicine specialist and an Endocrinologist practicing medicine in Brighton, Michigan. Dr. Fanous is rated as an Experienced provider by MediFind in the treatment of Hypoparathyroidism. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Hashimoto Thyroiditis, and Hyperparathyroidism.

Jennifer Harder is an Internal Medicine specialist and a Nephrologist practicing medicine in Brighton, Michigan. Dr. Harder is rated as undefined provider by MediFind in the treatment of Hypoparathyroidism. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Lupus Nephritis, Polycystic Kidney Disease, Diabetic Nephropathy, and Chronic Kidney Disease.

Nazar Mohammad is an Internal Medicine specialist and an Endocrinologist practicing medicine in Brighton, Michigan. Dr. Mohammad is rated as undefined provider by MediFind in the treatment of Hypoparathyroidism. His clinical expertise encompasses Hyperparathyroidism, Familial Glucocorticoid Deficiency, Glucocorticoid Resistance, and Hypoaldosteronism.

Dr. Heung graduated from the Boston University School of Medicine. After finishing his Internal Medicine training at the University of Cincinnati Hospitals, he completed Fellowship training in Nephrology at the University of Michigan Health System. He has been a member of the University of Michigan faculty since 2005, and currently serves as Associate Division Chief for Clinical Affairs in the Division of Nephrology. His primary clinical and research interests are in the areas of acute kidney injury and critical care nephrology. Dr. Heung is rated as undefined provider by MediFind in the treatment of Hypoparathyroidism. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Chronic Kidney Disease, Polycystic Kidney Disease, Autosomal Dominant Polycystic Kidney Disease, Alport Syndrome, and Kidney Transplant. Dr. Heung is board certified in Nephrology.

Dr. Margolis grew up in Canada and attended Medical School at University of Manitoba in Winnipeg. He trained in Internal Medicine at University of Texas, San Antonio and then completed Nephrology Training at The University of Toronto. He did research training and was a faculty member at New York University before coming to Michigan In 1995. Dr. Margolis is rated as undefined provider by MediFind in the treatment of Hypoparathyroidism. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Polycystic Kidney Disease, Autosomal Dominant Polycystic Kidney Disease, Chronic Kidney Disease, and Minimal Change Disease. Dr. Margolis is board certified in Internal Medicine and Nephrology.

Maria Browne is a primary care provider, practicing in Family Medicine in Brighton, Michigan. Dr. Browne is rated as an Experienced provider by MediFind in the treatment of Hypoparathyroidism. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Hypothyroidism, Glucocorticoid-Remediable Aldosteronism, Hypertension, and Familial Hypertension.

Shannon Browne is a primary care provider, practicing in Internal Medicine in Brighton, Michigan. Dr. Browne is rated as an Experienced provider by MediFind in the treatment of Hypoparathyroidism. His clinical expertise encompasses Wolcott Rallison Syndrome, Maturity Onset Diabetes of the Young, Glucocorticoid-Remediable Aldosteronism, and Familial Hypertension.

Dr. Gregory Clines is an Associate Professor of Internal Medicine in the Division of Metabolism, Endocrinology & Diabetes (MEND) at the University of Michigan. He received his MD and PhD degrees at the University of Texas Southwestern Medical Center at Dallas. He then completed internal medicine training at Duke University and an endocrinology fellowship at the University of Virginia. Before joining the University of Michigan in 2013, he was on the faculty at the University of Virginia and the University of Alabama at Birmingham.Dr. Clines has been studying and thinking about bone diseases for nearly 30 years. His basic science laboratory studies how novel factors such as hypoxia, androgens, endothelins, Wnt signaling, and other factors regulate the osteoblast-cancer cell synergy in bone metastasis. His other research interests include understanding how sex steroids regulate skeletal size and shape, and the development of novel imaging techniques to assess bone quality.His clinical interests include metabolic and genetic bone diseases as well as general endocrinology. Dr. Clines sees patients at the Metabolism, Endocrinology & Diabetes Clinic (Metabolic Bone Disease Clinic) and at the Ann Arbor Veterans Affairs Medical Center. Dr. Clines is rated as an Advanced provider by MediFind in the treatment of Hypoparathyroidism. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Osteoporosis, Paget's Disease of Bone, Postmenopausal Osteoporosis, Thyroidectomy, and Orchiectomy. Dr. Clines is board certified in Endocrinology, Diabetes & Metabolism.

Dr. Chun is a physician-scientist, who practices general endocrinology, including diabetes, thyroid diseases, and metabolic syndrome. His research is focused on the cellular and molecular mechanism of obesity, diabetes, and inflammatory and fibrotic tissue damages in endocrine disorders, such as Graves’ eye disease. Dr. Chun is rated as an Experienced provider by MediFind in the treatment of Hypoparathyroidism. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Hyperparathyroidism, Neonatal Severe Hyperparathyroidism, Osteitis Fibrosa, and Familial Isolated Hyperparathyroidism. Dr. Chun is board certified in Endocrinology, Diabetes & Metabolism and Internal Medicine.

Megan R. Haymart, MD is Professor of Internal Medicine with an appointment in the Division of Metabolism, Endocrinology, and Diabetes at the University of Michigan. She holds the Nancy Wigginton Endocrinology Research Professorship of Thyroid Cancer and is Director of Thyroid Cancer Research at the University of Michigan. Dr. Haymart received her medical degree at Johns Hopkins University School of Medicine and completed her internal medicine residency at Johns Hopkins Hospital. She then completed a fellowship in endocrinology, diabetes, and metabolism at the University of Wisconsin. She has been faculty at the University of Michigan since 2009.Dr. Haymart has a history of NIH-funded research focused on optimizing thyroid care delivery. She is a health services researcher who primarily studies thyroid cancer care across the disease continuum: from the diagnosis of a thyroid nodule to cancer survivorship. In recognition of her research, she received the American Thyroid Association’s Van Meter Award for outstanding contributions to research on the thyroid gland (2017), the University of Michigan’s Jerome Conn Award for Research Excellence (2017), membership to American Society for Clinical Investigation (2018), the AACE Hossein Gharib Education Lectureship Award for exemplary contributions to an individual profession or area of expertise (2021), and the inaugural AACE Endocrine Care Innovation Award in recognition of her team’s outstanding body of work focused on clinical outcomes or health care delivery (2025).Dr. Haymart is actively involved in improving research infrastructure at the University of Michigan. This includes her roles as Assistant Director of Data Solutions for AI & Digital Health Innovation, faculty support for MICHR, and co-Director of Patient’s First. She also devotes time to mentoring junior faculty and trainees resulting in her receipt of the MICHR Distinguished Clinical and Translational Research Mentor Award (2021) and the Women in Thyroidology and American Thyroid Association Woman of the Year Award (2021) for promoting the advancement of women, both within the organization and field. Dr. Haymart is rated as an Experienced provider by MediFind in the treatment of Hypoparathyroidism. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Thyroid Cancer, Thyroid Nodule, Papillary Thyroid Cancer, Thyroidectomy, and Hormone Replacement Therapy (HRT). Dr. Haymart is board certified in Endocrinology, Diabetes & Metabolism.

Cristina Nieves is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Nieves is rated as an Experienced provider by MediFind in the treatment of Hypoparathyroidism. She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses Toxic Nodular Goiter, Thyroid Storm, Type 2 Diabetes (T2D), and Low Blood Sugar. Dr. Nieves is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Dr. Lynn Ang is currently a Clinical Associate Professor in the Metabolism, Endocrinology, and Diabetes Division, Internal Medicine Department at University of Michigan. Dr. Ang is one of the principle attending physicians for the Diabetes Transition Program. Dr. Ang’s clinical and research interests are in the fields of implementing optimal management of inpatient and outpatient hyperglycemia, creating protocols for inpatient hospital guidelines, identifying biomarkers to predict the development or progression of diabetic complications, detecting the earliest stages of complications to prevent progression of diseases, and developing sensitive diagnostic methods/treatment for those complications. Dr. Ang also serves as a Co-Director of Hospital Intensive Insulin Program. Dr. Ang has been actively involving in teaching internal medicine and podiatry residents, endocrinology fellows, and medical students in both ambulatory and inpatient clinical settings. She was a recipient of Goran Sundkvist Young Investigators Award for Clinical Science 2022. Dr. Ang is rated as an Experienced provider by MediFind in the treatment of Hypoparathyroidism. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Diabetic Neuropathy, Type 2 Diabetes (T2D), and Maturity Onset Diabetes of the Young. Dr. Ang is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Yu Kuei Alex Lin is a Clinical Assistant Professor of Internal Medicine, Division of Metabolism, Endocrinology & Diabetes (MEND). After earning his medical degree at Poznan University of Medical Sciences, Poland, he completed his Medicine Residency at Beth Israel Medical Center, NY, and Endocrinology fellowship at Cleveland Clinic, OH. Dr. Lin joined the faculty at Michigan in 2019.Dr. Lin is a clinical diabetes researcher with research focuses on characterizing hypoglycemia (including evaluating impaired awareness of hypoglycemia and unhelpful hypoglycemia beliefs and management behaviors and their associations with hypoglycemia developments) and devising and testing behavioral interventions for improving hypoglycemia self-management. Dr. Lin’s clinical practice focuses on diabetes and general endocrinology. Dr. Lin is rated as an Experienced provider by MediFind in the treatment of Hypoparathyroidism. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Low Blood Sugar, Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Pancreatectomy, and Islet Cell Transplantation. Dr. Lin is board certified in Endocrinology, Diabetes & Metabolism.

Dr. Elif Oral is a professor in the Division of Metabolism, Endocrinology and Diabetes (MEND) at the University of Michigan. She completed her medical education in her home country of Turkey at the University of Istanbul. In 1996, she completed her residency in Internal Medicine at Sinai Hospital Detroit (Michigan). She then completed a fellowship in Endocrinology, Metabolism and Diabetes at the National Institute of Health, where she also chose to stay as a Senior Fellow under the mentorship of Drs SimeonTaylor and Phillip Gorden in in the Diabetes Branch of NIDDK.Since joining the University of Michigan in 2002 as an Assistant Professor of Medicine, along with her regular faculty responsibilities, Dr. Oral also completed a Masters of Science Degree in Clinical Research Design and Biostatistics at the School of Public Health. Her clinical interests are in insulin resistance, obesity, lipid disorders, and diabetes.Dr Oral's research focuses on the importance of adipocytes in human metabolism and adipocyte hormones such as leptin. She is best known for her work showing the remarkable efficacy of leptin in rare lipodystrophy syndromes. Metreleptin received approval by the FDA (2014) and EMA (2016) as a treatment for lipodystrophy owing to a large part to her original vision and work. These studies provided the basis for her current work with three big goals: identification of novel metabolic diseases, discovery of new disease mechanisms and finding treatments for patients afflicted with these disorders. In addition to her roles as physician, educator, and researcher, Dr Oral is also the director of two programs at MEND: Atypical Diabetes Program and Obesity and Metabolic Disorders Program. She directed the Post-Bariatric Surgery Care Program from 2012 to 2021 and continues to conduct research on the cohort of patients who had bariatric surgery performed in the Michigan Bariatric Surgery program. Dr. Oral is rated as an Experienced provider by MediFind in the treatment of Hypoparathyroidism. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Familial Partial Lipodystrophy, Congenital Generalized Lipodystrophy, Familial Hypertriglyceridemia, Gastric Bypass, and Sleeve Gastrectomy. Dr. Oral is board certified in Endocrinology, Diabetes & Metabolism.

Liselle Douyon is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Douyon is rated as an Experienced provider by MediFind in the treatment of Hypoparathyroidism. She is also highly rated in 37 other conditions, according to our data. Her clinical expertise encompasses Postmenopausal Osteoporosis, Osteoporosis, Thyroid Nodule, and Juvenile Primary Osteoporosis.

Zahrae Sandouk M.D., is a Clinical Assistant Professor, board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism and a graduate from Henry Ford Hospital and Cleveland Clinic who has an interest in Diabetes mellitus, Diabetes complications, Cystic Fibrosis related Diabetes, Pituitary disorders, Prolactinoma, Hypopituitarism, Thyroid disorders, Bone and calcium disorders, Adrenal and Osteoporosis. Also the medical director of the Endocrine Testing Unity at the University of Michigan where dynamic studies are performed and is also part of the Cystic Fibrosis multidisciplinary team. Dr. Sandouk is rated as an Experienced provider by MediFind in the treatment of Hypoparathyroidism. She is also highly rated in 39 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Adrenal Insufficiency Pediatric, Type 2 Diabetes (T2D), and Thyroid Nodule. Dr. Sandouk is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Doctor Jennifer Wyckoff is a Clinical Professor of Internal Medicine in the Metabolism, Endocrinology and Diabetes/Podiatry Division. She received her MD degree from the University of South Florida in 1992 and completed her Internal Medicine Residency at the University of Utah in 1995. In addition, Dr. Wyckoff completed a fellowship in Endocrinology at the Brigham and Women's Hospital, Harvard Medical School, in 1999. Following that, she joined the faculty of the Joslin Diabetes Center, Harvard Medical School. While there, she practiced as part of the multidisciplinary Diabetes and Pregnancy program, a joint venture between the Joslin Diabetes Center and the Beth Israel Deaconess Hospital.In 2006, she joined the faculty at University of Michigan. Dr. Wyckoff serves as the Associate Clinical Chief for the Metabolism, Endocrinology and Diabetes/Podiatry Division and the Medical Director of the Adult Diabetes Education. Her clinical interests center on diabetes, with specific emphasis on diabetes and pregnancy, Type 1 diabetes and technology, patient education and cystic fibrosis related diabetes. Dr. Wyckoff is rated as an Experienced provider by MediFind in the treatment of Hypoparathyroidism. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Secondary Immunodeficiency (SID), and Gestational Diabetes. Dr. Wyckoff is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Nazanene H. Esfandiari, MD, is a Clinical Professor of Internal Medicine with an appointment in the Division of Metabolism, Endocrinology and Diabetes (MEND). Dr. Esfandiari received her medical degree from the University of Bordeaux in France, completed internal medicine residency in France and at UMASS Memorial Health Center in Massachusetts, and then completed fellowship in endocrinology at the University of Michigan. She joined the faculty at the University of Michigan in 2003. She was inducted into Clinical Excellence Society at the University of Michigan in 2014. She is the MEND Service Chief, Co-director of Hospital Intensive Insulin Program (HIIP) and Assistant Chief for the Inpatient Endocrine Consult.Dr. Esfandiari’s practice focuses on thyroid cancer, thyroid disorders, post bariatric care, and diabetes. She is also interested in medical education and is the Co-director of the Endocrine Sequence at the University of Michigan Medical School. In addition, Dr. Esfandiari has served in several national committees at the Endocrine Society and American Thyroid Association (ATA). Dr. Esfandiari is rated as an Experienced provider by MediFind in the treatment of Hypoparathyroidism. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Thyroid Cancer, Follicular Thyroid Cancer, Anaplastic Thyroid Cancer, Gastric Bypass, and Thyroidectomy. Dr. Esfandiari is board certified in Endocrinology, Diabetes & Metabolism.